SAC Capital Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-2,395
Closed -$3.32M 1053
2014
Q1
$3.32M Buy
+2,395
New +$3.32M 0.02% 585